The La Jolla Institute for Allergy & Immunology joined the Sanford Consortium for Regenerative Medicine, along with the Salk Institute, The Scripps Research Institute, UCSD and the Sanford-Burnham Medical Research Institute.
Slated to open the new collaborative research facility in November, the Consortium aims to improve human health through stem cell research.
“We are pleased that the La Jolla Institute has accepted our invitation to join the Sanford Consortium,” said Edward W. Holmes, M.D., the Consortium’s president and chief executive officer, adding that the La Jolla Institute’s strong immunology expertise will complement and expand that of the collaborating organizations.”
Mitchell Kronenberg, Ph.D., La Jolla Institute president and chief scientific officer, said the Consortium “will foster the kind of cross-disciplinary, cross-institutional research that accelerates discovery and leads to breakthroughs.
La Jolla Institute faculty member Anjana Rao, Ph.D., a prominent genetics and cell biology researcher, will move part of her lab into the new Consortium building. Dr. Kronenberg becomes a member of the Consortium’s 10-member Board of Directors, which includes UCSD Chancellor Marye Anne Fox, Ph.D., and leaders from the other collaborating organizations. The board is co-chaired by Irwin M. Jacobs, Malin Burnham and John Moores, and South Dakota-based philanthropist T. Denny Sanford, who provided a $30 million naming gift to the Consortium.